Septerna

Septerna is a clinical-stage biotechnology company developing oral small-molecule drugs that target G protein-coupled receptors (GPCRs). Its Native Complex Platform lets it produce stable, functional GPCRs outside the cell, which supports drug discovery against targets that were previously hard to reach. Its pipeline spans endocrine, metabolic and other diseases, and it has partnerships including one with Vertex.